Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Werewolf Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-01-06
Purchase
2023-01-10
5:14 pm
Werewolf Therapeutics Inc.HOWLRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,853,000$2.21$4,095,1306,144,881
(Indirect)
View
2021-12-15
Sale
2021-12-17
4:17 pm
Werewolf Therapeutics Inc.HOWLLeonard Reid
Chief Operating Officer
3,000$13.41$40,242122,157
(Indirect)
View
2021-06-14
Purchase
2021-06-16
4:58 pm
Werewolf Therapeutics Inc.HOWLRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
323,298$12.77$4,129,3984,291,881
(Indirect)
View
2021-05-04
Purchase
2021-05-06
4:31 pm
Werewolf Therapeutics Inc.HOWLRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,715,000$16$27,440,000443,825
(Indirect)
View
2021-05-04
Purchase
2021-05-06
4:20 pm
Werewolf Therapeutics Inc.HOWLMPM BioVentures 2014 L.P.
MPM BioVentures 2014 (B) L.P.
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
Foley Todd
MPM Asset Management Investors BV2014 LLC
10% Owner
125,759$16$2,012,1443,187,998
(Indirect)
View
2021-05-04
Purchase
2021-05-06
4:19 pm
Werewolf Therapeutics Inc.HOWLGADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
245,000$16$3,920,0006,672,183
(Indirect)
View
2020-12-23
Purchase
2021-05-06
4:19 pm
Werewolf Therapeutics Inc.HOWLEVNIN LUKE
Director
10% Owner
150,799$16$2,412,78412,224,142
(Indirect)
View
2021-05-04
Purchase
2021-05-04
4:31 pm
Werewolf Therapeutics Inc.HOWLTaiho Ventures LLC
10% Owner
312,500$16$5,000,0002,068,909
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-03
Option Award
2023-01-09
9:38 pm
N/A
2032-12-31
Werewolf Therapeutics Inc.HOWLHICKLIN DANIEL J
See Remarks
295,500$0295,500
(Direct)
View
2023-01-03
Option Award
2023-01-09
9:36 pm
N/A
2032-12-31
Werewolf Therapeutics Inc.HOWLLubman Ellen
Chief Business Officer
86,200$086,200
(Direct)
View
2023-01-03
Option Award
2023-01-09
9:36 pm
N/A
2032-12-31
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
115,900$0115,900
(Direct)
View
2023-01-03
Option Award
2023-01-09
9:35 pm
N/A
2032-12-31
Werewolf Therapeutics Inc.HOWLKarunatilake Chulani
Chief Technology Officer
103,600$0103,600
(Direct)
View
2023-01-03
Option Award
2023-01-09
9:35 pm
N/A
2032-12-31
Werewolf Therapeutics Inc.HOWLTrost Timothy W.
Chief Financial Officer
102,800$0102,800
(Direct)
View
2023-01-03
Option Award
2023-01-09
9:34 pm
N/A
2032-12-31
Werewolf Therapeutics Inc.HOWLLeonard Reid
Chief Operating Officer
93,600$093,600
(Direct)
View
2023-01-03
Option Award
2023-01-09
9:32 pm
N/A
2032-12-31
Werewolf Therapeutics Inc.HOWLIsaacs Randi
Chief Medical Officer
103,300$0103,300
(Direct)
View
2022-06-01
Option Award
2022-06-03
5:30 pm
N/A
2032-05-31
Werewolf Therapeutics Inc.HOWLRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
11,600$011,600
(Indirect)
View
2022-06-01
Option Award
2022-06-03
4:42 pm
N/A
2032-05-31
Werewolf Therapeutics Inc.HOWLEVNIN LUKE
Director
11,600$011,600
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:42 pm
N/A
2032-05-31
Werewolf Therapeutics Inc.HOWLDiRocco Derek
Director
11,600$011,600
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:41 pm
N/A
2032-05-31
Werewolf Therapeutics Inc.HOWLMorrison Briggs
Director
11,600$011,600
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:40 pm
N/A
2032-05-31
Werewolf Therapeutics Inc.HOWLKarunatilake Chulani
Chief Technology Officer
136,000$0136,000
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:39 pm
N/A
2032-05-31
Werewolf Therapeutics Inc.HOWLSherman Michael A.
Director
11,600$011,600
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:39 pm
N/A
2032-05-31
Werewolf Therapeutics Inc.HOWLLazarus Alon
Director
11,600$011,600
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:39 pm
N/A
2032-05-31
Werewolf Therapeutics Inc.HOWLChatterjee Meeta
Director
7,733$07,733
(Direct)
View
2022-01-06
Option Award
2022-01-18
6:34 pm
N/A
2032-01-05
Werewolf Therapeutics Inc.HOWLIsaacs Randi
Chief Medical Officer
79,516$079,516
(Direct)
View
2022-01-06
Option Award
2022-01-18
6:33 pm
N/A
2032-01-05
Werewolf Therapeutics Inc.HOWLLeonard Reid
Chief Operating Officer
70,967$070,967
(Direct)
View
2022-01-06
Option Award
2022-01-18
6:32 pm
N/A
2032-01-05
Werewolf Therapeutics Inc.HOWLTrost Timothy W.
Chief Financial Officer
65,960$065,960
(Direct)
View
2022-01-06
Option Award
2022-01-18
6:31 pm
N/A
2032-01-05
Werewolf Therapeutics Inc.HOWLHICKLIN DANIEL J
See Remarks
215,888$0215,888
(Direct)
View
2022-01-06
Option Award
2022-01-18
6:30 pm
N/A
2032-01-05
Werewolf Therapeutics Inc.HOWLLubman Ellen
Chief Business Officer
51,088$051,088
(Direct)
View
2022-01-06
Option Award
2022-01-18
6:29 pm
N/A
2032-01-05
Werewolf Therapeutics Inc.HOWLKarunatilake Chulani
Chief Technology Officer
34,258$034,258
(Direct)
View
2022-01-06
Exercise
2022-01-14
5:58 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
15,532$4.77364,972
(Direct)
View
2022-01-06
Exercise
2022-01-14
5:58 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
24,199$1.56364,972
(Direct)
View
2022-01-06
Exercise
2022-01-14
5:58 pm
N/A
2030-05-19
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
39,731$0364,972
(Direct)
View
2022-01-06
Option Award
2022-01-14
5:58 pm
N/A
2032-01-05
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
79,516$0364,972
(Direct)
View
2021-12-30
Exercise
2022-01-04
4:26 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLLeonard Reid
Chief Operating Officer
14,102$1.56183,293
(Direct)
View
2021-12-30
Exercise
2022-01-04
4:26 pm
N/A
2030-05-19
Werewolf Therapeutics Inc.HOWLLeonard Reid
Chief Operating Officer
14,102$0183,293
(Direct)
View
2021-10-28
Option Award
2021-11-01
4:12 pm
N/A
2031-10-27
Werewolf Therapeutics Inc.HOWLChatterjee Meeta
Director
23,200$023,200
(Direct)
View
2021-07-01
Option Award
2021-07-02
08:26 am
N/A
2031-06-30
Werewolf Therapeutics Inc.HOWLKarunatilake Chulani
Chief Technology Officer
272,000$0272,000
(Direct)
View
2021-05-27
Option Award
2021-05-28
08:07 am
N/A
2031-05-26
Werewolf Therapeutics Inc.HOWLSherman Michael A.
Director
23,200$023,200
(Direct)
View
2021-05-04
Conversion
2021-05-06
4:31 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
21,790,133$0443,825
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:20 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLMPM BioVentures 2014 L.P.
MPM BioVentures 2014 (B) L.P.
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
Foley Todd
MPM Asset Management Investors BV2014 LLC
10% Owner
29,609,106$03,187,998
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLGADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
57,683,698$06,672,183
(Indirect)
View
2020-12-23
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLEVNIN LUKE
Director
10% Owner
35,504,612$012,224,142
(Indirect)
View
2021-05-04
Conversion
2021-05-05
4:00 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLHBM Healthcare Investments (Cayman) Ltd.
10% Owner
6,052,814$0625,995
(Direct)
View
2021-05-04
Conversion
2021-05-04
4:31 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLTaiho Ventures LLC
10% Owner
16,982,900$02,068,909
(Direct)
View
2021-04-30
Option Award
2021-05-04
4:31 pm
N/A
2031-04-29
Werewolf Therapeutics Inc.HOWLDiRocco Derek
Director
23,200$023,200
(Direct)
View
2021-02-12
Option Award
2021-05-04
4:31 pm
N/A
2031-02-11
Werewolf Therapeutics Inc.HOWLTrost Timothy W.
Chief Financial Officer
302,568$0302,568
(Direct)
View
Goto 0, 1, Next